Hitachi America, a subsidiary of Hitachi, has obtained FDA clearance for spot scanning irradiation technology of its Proton Beam therapy system for application at the MD Anderson Cancer Center in the US.
Subscribe to our email newsletter
Proton Beam therapy is a new and remarkable type of cancer treatment that minimizes the unnecessary irradiation to the normal tissue compared with conventional electron beam and x-ray radiation therapy.
With this newly-developed technology, Hitachi expects to enhance its presence and position in the proton beam market in North America.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.